Health Canada Temporarily Authorizes Dexcom G6 CGM for Use in Hospitals to Monitor Critically Ill Patients During COVID-19 Pandemic
"This has been an incredibly trying time, especially for our front-line health care workers who are putting their own health at risk, day in and day out, to ensure the health and safety of those around them," said
The Dexcom G6 CGM System uses a small, wearable sensor and transmitter to continuously measure and send glucose levels wirelessly to a smart device or receiver†, giving patients and now caregivers of critically ill patients, real-time glucose data without the need for a fingerprick.‡
With customizable alerts and alarms, Dexcom G6 CGM system will remotely alert health care providers treating COVID-19 patients in hospital if a patient is experiencing an urgent hyper- or hypoglycemic event. In addition to providing real-time glucose values, Dexcom CGM systems also display the direction and rate of glucose change, empowering health care providers to take proactive measures to help keep patient glucose levels in target range.
Healthcare facilities interested in using real-time CGM systems to remotely monitor COVID-19 patients should contact COVIDfirstname.lastname@example.org.
*Internet connectivity required for data sharing. Following requires the use of the Follow App. Followers should always confirm readings on the Dexcom G6 app or receiver before making treatment decisions.
†For a list of compatible devices, visit www.dexcom.com/compatibility.
‡ If your glucose alerts and readings from Dexcom G6 do not match your symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.